SCHEMBL435330

SCHEMBL435330

CCOC(=O)/C=C/c1ccc(OC)cc1Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.49
ALDH1A1 P00352 2/20 0.49
MAPT P10636 2/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
KDM4E B2RXH2 1/20 0.48
HPGD P15428 1/20 0.48
FDPS P14324 1/20 0.47
TTR P02766 1/20 0.47
DPP4 P27487 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
CA14 Q9ULX7 1/20 0.47
ESR1 P03372 2/20 0.46
LY96 Q9Y6Y9 1/20 0.46
CYP3A4 P08684 2/20 0.46
CYP1A2 P05177 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19257215 0.90 MAOB (0.48) MAOBALDH1A1MAPTMEN1KMT2A
SCHEMBL16864064 0.87 HDAC8 (0.49) MAOBFDPSTTRDPP4CA12
SCHEMBL28139586 0.86 MAOB (0.56) MAOBALDH1A1MAPTMEN1KMT2A
SCHEMBL18538452 0.86 MAOB (0.56) MAOBALDH1A1MAPTMEN1KMT2A
SCHEMBL4592405 0.86 MAPT (0.68) MAOBALDH1A1MAPTMEN1KMT2A
SCHEMBL4592398 0.86 MAPT (0.68) MAOBALDH1A1MAPTMEN1KMT2A
SCHEMBL30637013 0.85 TTR (0.49) MAOBALDH1A1MAPTFDPSTTR
SCHEMBL11821125 0.85 TTR (0.49) MAOBALDH1A1MAPTFDPSTTR
SCHEMBL13686175 0.84 CYP1A2 (0.51) MAOBALDH1A1MAPTMEN1KMT2A
SCHEMBL1587040 0.84 CYP1A2 (0.51) MAOBALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2595952-B1 AGONISTS OF GPR40 CONNEXIOS LIFE SCIENCES PVT LTD (IN) 2020-11-18 EP disclosed
US-9278915-B2 Agonists of GPR40 CONNEXIOS LIFE SCIENCES PVT LTD (IN) 2016-03-08 US disclosed
US-9278915-B2 Agonists of GPR40 CONNEXIOS LIFE SCIENCES PVT LTD (IN) 2016-03-08 US disclosed
US-20130237571-A1 AGONISTS OF GPR40 Conexios Life Sciences PVT. LTD. (IN) 2013-09-12 US disclosed
US-20130237571-A1 AGONISTS OF GPR40 Conexios Life Sciences PVT. LTD. (IN) 2013-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130237571-A1 AGONISTS OF GPR40 GPR65, GPR55, GPR68 MAOB 2832/4885ALDH1A1 2410/4885MAPT 2792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.